China SXT Pharmaceuticals (SXTC) Non-Current Assets (2018 - 2025)

China SXT Pharmaceuticals' Non-Current Assets history runs 8 years deep, the most recent figure standing at $310889.0 for Q3 2025.

• In Q3 2025, Non-Current Assets fell 96.55% year-over-year to $310889.0; the TTM figure through Sep 2025 stood at $310889.0 (down 96.55% YoY), while the FY2025 annual figure was $367017.0, down 95.87% from the prior year.
• Non-Current Assets was $310889.0 for Q3 2025 at China SXT Pharmaceuticals, down from $367017.0 in the prior quarter.
• In the past five years, Non-Current Assets ranged from a high of $11.3 million in Q1 2021 to a low of $310889.0 in Q3 2025.
• Historically, Non-Current Assets has averaged $7.3 million across 5 years, with a median of $9.4 million in 2022.
• The sharpest annual moves came in 2024 and 2025: Non-Current Assets surged 724.5% in 2024, then plunged 96.55% in 2025.
• A 5-year view of Non-Current Assets shows it stood at $11.0 million in 2021, then declined by 10.79% to $9.8 million in 2022, then slumped by 88.87% to $1.1 million in 2023, then soared by 724.5% to $9.0 million in 2024, then slumped by 96.55% to $310889.0 in 2025.
• The last three Non-Current Assets figures came in at $310889.0 (Q3 2025), $367017.0 (Q1 2025), and $9.0 million (Q3 2024), per Business Quant data.